| Financial Year |
March 31 2023 |
| Monetary Funds |
803,881,447.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
670,000.00 |
| Accounts Receivable |
55,797,872.21 |
| Advances to Suppliers |
58,010,787.13 |
| Other Receivables |
39,843,550.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
955,376,986.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
204,458,961.37 |
| Total Current Assets |
2,118,039,605.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,700,000.00 |
| Long-term Equity Investment |
27,543,085.23 |
| Investment Properties |
81,862,092.16 |
| Fixed Assetes |
3,747,710,997.52 |
| Under-construction Projects |
1,912,995,675.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
286,601,272.40 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
283,782,859.22 |
| R&D expenses |
-- |
| Goodwill |
65,162,760.64 |
| Long-Term Deferred and Prepaid Expenses |
68,133,226.54 |
| Deferred Income Tax Assets |
19,028.54 |
| Other Non-Current Assets |
16,040,518.22 |
| Sub-Total of Non-Current Assets |
6,695,342,763.51 |
| Total Assets |
8,813,382,369.17 |
| Short-Term Loans |
1,490,711,292.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
516,330,090.31 |
| Accounts Received In Advance |
5,419,212.33 |
| Employee Compensation Payable |
59,270,493.17 |
| Taxes Payable |
8,842,912.12 |
| Interest Payable |
-- |
| Dividend Payable |
62,899.22 |
| Other payables |
152,446,471.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
584,079,896.23 |
| Other Current Liabilities |
4,459,932.73 |
| Sub-Total of Current Liabilities |
2,904,990,178.63 |
| Long-term Loans |
1,765,116,655.05 |
| Bonds Payable |
285,597,434.87 |
| Long-Term Accounts Payable |
203,548,833.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,222,691.83 |
| Other Non-Current Liabilities |
363,208,109.59 |
| Sub-Total of Non-Current Liabilities |
3,156,520,412.39 |
| Total Liabilities |
6,061,510,591.02 |
| Paid-In Capital(Or Share Stock) |
612,909,455.00 |
| Capital Surplus |
1,385,815,958.94 |
| Surplus Reserve |
78,638,547.58 |
| LESS:Treasury Stock |
105,104,860.80 |
| Undistributed Profits |
550,853,135.72 |
| Minority Stockholder's Interest |
202,081,556.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,549,790,221.25 |
| Owner's Equity（Stockholder's Equity） |
2,751,871,778.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,813,382,369.17 |
